Aspartate N-acetyltransferase (NAT8L), a NAA biosynthetic enzyme, was negatively associated with overall survival duration in CRC patients, as shown in the cancer genome atlas (TCGA) (53). This evidence concerns the gene ASPNAT and colorectal carcinoma.